Vignesh Subramanian ’24 A number of neurodegenerative disease processes, including those of temporal lobe epilepsy, GABA-transaminase deficiency, and traumatic brain injury, involve disruptions to the signalling pathway of gamma-aminobutyric acid (GABA), the chief inhibitory neurotransmitter of the central nervous system. Conventional understanding divides the ability of GABA to block neural signaling into ‘presynaptic inhibition’ – involving suppression of glutamate release,  an excitatory counterpart neurotransmitter – … Continue reading Presynaptic Inhibition of GABAA Receptors Possible in Thalamocortical Circuits